Journal of Comprehensive Pediatrics

Published by: Kowsar

Shwachman Score in Clinical Evaluation of Cystic Fibrosis

Soheila Khalilzadeh 1 , Maryam Hassanzad 1 , Nooshin Baghaie 1 , Nazanin Parsanejad 1 , Mohammad Reza Boloursaz 1 and Fanak Fahimi 2 , *
Authors Information
1 Pediatric Respiratory Disease Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University, Tehran, IR Iran
2 Chronic Respiratory Disease Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University, Tehran, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: February 25, 2013, 4 (1); 82-5
  • Published Online: October 20, 2012
  • Article Type: Research Article
  • Received: July 1, 2012
  • Revised: August 28, 2012
  • Accepted: September 11, 2012
  • DOI: 10.17795/compreped-4558

To Cite: Khalilzadeh S, Hassanzad M, Baghaie N, Parsanejad N, Boloursaz M R, et al. Shwachman Score in Clinical Evaluation of Cystic Fibrosis, J Compr Ped. 2013 ; 4(1):82-5. doi: 10.17795/compreped-4558.

Abstract
Copyright © 2012, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med. 2006; 173(5): 475-82[DOI][PubMed]
  • 2. Moss RB. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. Chest. 2002; 121(1): 55-63[DOI][PubMed]
  • 3. Jaffe A, Bush A. Cystic fibrosis: review of the decade. Monaldi Arch Chest Dis. 2001; 56(3): 240-7[PubMed]
  • 4. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 1996; 335(3): 179-88[DOI][PubMed]
  • 5. Goss CH, Mayer-Hamblett N, Kronmal RA, Ramsey BW. The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases. Ad Drug Deli Rev. 2002; 54(11): 1505-28[DOI]
  • 6. Cystic fibrosis in the 20th century : people, events, and progress. 2001;
  • 7. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996; 154(5): 1229-56[PubMed]
  • 8. Katz JN, Horwitz RI, Dolan TF, Shapiro ED. Clinical features as predictors of functional status in children with cystic fibrosis. J Ped. 1986; 108(3): 352-8[DOI]
  • 9. Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child. 1958; 96(1): 6-15[PubMed]
  • 10. Dankert-Roelse JE, te Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre. Thorax. 1995; 50(7): 712-8[DOI][PubMed]
  • 11. Taussig LM, Kattwinkel J, Friedewald WT, di Sant'Agnese PA. A new prognostic score and clinical evaluation system for cystic fibrosis. J Ped. 1973; 82(3): 380-90[DOI]
  • 12. Helbich TH, Heinz-Peer G, Eichler I, Wunderbaldinger P, Gotz M, Wojnarowski C, et al. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology. 1999; 213(2): 537-44
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments